Startup
I
iCUREX
Chitosan hydrogel wound dressing (Kitosura CX), a Class III medical device launched in September 2026.
Funding rounds in 2026
Amounts are the full announced figure. Grey amounts aren't counted in equity totals. † includes debt, grants or other non-equity (hover for detail).
| Date | Company | Stage | Amount | Investors | Sector |
|---|---|---|---|---|---|
| 22 Oct 2026 | IiCUREX | Series A first close | ¥140M† | NCB Venture CapitalGreen CoreINDEP | HealthcareDeep tech |